Analysis of the Cost Effectiveness of Home-Based Phototherapy With Narrow-Band UV-B Radiation Compared With Biological Drugs For the Treatment of Moderate to Severe Psoriasis

Vañó‐Galván, Sergio; Gárate, M.T.; Fleta-Asín, Beatriz; Hidalgo, Álvaro; Fernández‐Guarino, M.; Bermejo, Teresa; Jaén, Pedro

doi:10.1016/j.adengl.2012.03.003

Cited by 11 publications

(9 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…El biológico ustekinumab, está dirigido contra la subunidad p40 de las citocinas IL-12 e IL-23. Ha proporcionado una nueva vía de terapia para una variedad de enfermedades mediadas por células T. Los productos biológicos son generalmente seguros; Sin embargo, ha habido preocupación sobre el riesgo de linfoma con el uso de estos agentes (3,4).…”

Section: Resultsunclassified

Terapia biológica para la psoriasis moderada a severa

Freire

Proaño

Barrera

et al. 2020

jah

View full text Add to dashboard Cite

La psoriasis es una enfermedad inflamatoria, crónica y sistémica que afecta a la piel, articulaciones, suele estar asociada a comorbilidades de aspectos inflamatorios e inmunológicos; presentamos una actualización sobre los fármacos biológicos que han demostrado eficacia en esta entidad en fases moderadas a severas mediante revisión de documentos secundarios donde destacan los biológicos con mayor evidencia científicas. Los tratamientos sistemáticos pueden reducir la gravedad de los síntomas y evitar daños adicionales por lo que se debe iniciar terapia oportuna, con el fin de detener la progresión de los síntomas cutáneos y posiblemente reducir los sistémicos.

show abstract

Section: Resultsunclassified

Terapia biológica para la psoriasis moderada a severa

Freire

Proaño

Barrera

et al. 2020

jah

View full text Add to dashboard Cite

show abstract

“…La fototerapia-fotoquimioterapia es un tratamiento que se utiliza cuando las placas son muy extensas, y los tratamientos tópicos han fracasado 14 . Este tipo de tratamiento es muy eficaz y además es coste-efectivo 21 . Carece de efectos tóxicos sistémicos y propiedades inmunosupresoras 3 .…”

Section: Psoriasis Moderadaunclassified

“…Estos outputs afectan al diagnóstico (outputs 1-3), seguimiento y tratamiento de la psoriasis leve (outputs 4-5), seguimiento y tratamiento de la psoriasis moderada (outputs 6-14) y seguimiento y tratamiento de la psoriasis grave (outputs [15][16][17][18][19][20][21][22]. Finalmente se han incluido dos outputs globales que afectan a la psoriasis moderada y grave.…”

Section: Outputsunclassified

See 1 more Smart Citation

Retorno social de la inversión de un abordaje ideal de la Psoriasis

González¹,

Ivanova²,

Jiménez³

et al. 2016

View full text Add to dashboard Cite

“…Phototherapy Ultraviolet B (UVB) for example, has been revealed to be safe, efficacious and cost effective. In cases where the patients did not respond well to UVB monotherapy, a combination of UVB and acitretin is given regularly (Bhosle et al 2006;Vañó-Galván et al 2012). …”

Section: Introductionmentioning

confidence: 99%

Economic Burden and Cost Effectiveness Analysis of Psoriasis Treatment Modalities in Malaysian Public Hospitals: A Study Protocol

Sulong¹,

Ismail²,

Azizam³

et al. 2016

European Proceedings of Social &Amp; Behavioural Sciences

View full text Add to dashboard Cite

There is limited evidence on the economic burden and cost effectiveness of psoriasis treatment modalities in this region. This study aims to evaluate the economic burden and cost effectiveness analysis of four Psoriasis treatment modalities in Malaysian public hospitals. This is a prospective cohort study involving a total of 523 moderate to severe psoriasis patients (Psoriasis Area Severity Index (PASI)>10and/or Body Surface Area (BSA)>10 and/or Dermatology Life Quality Life (DLQI)>10) recruited from five public hospitals in Malaysia via consecutive sampling technique. The duration of the data collection is 12 months (6 months recruitment and 6 months follow up). Inclusion criteria include new or existing moderate to severe psoriasis patients who started with new treatment modalities at the time of the recruitment period, Malaysians, aged 18 years and above and who are willing to participate. The costs are calculated from the societal perspective. Provider costs are calculated by estimating recurrent costs (emolument, consumables, utility, maintenance and training) and direct costs (drugs, laboratory investigation, procedural examination). Patient costs components are direct and indirect costs. Direct costs include treatment cost (traditional medicines), out of pocket expenses (over the counter drugs, skin supplements and products). Indirect costs covers transportation and loss of productivity. Economic burden is measured by multiplying the total cost with the prevalence of psoriasis. Effectiveness of the treatment modalities is assessed based on PASI, BSA and DLQI scores (outcomes). PASI-75 (75% reduction of PASI score from baseline score), BSA<5 and DLQI≤5 (disease has no or minimal impact on quality of life) is considered effective. The least cost per outcome is the most cost effective treatment.

show abstract

Analysis of the Cost Effectiveness of Home-Based Phototherapy With Narrow-Band UV-B Radiation Compared With Biological Drugs For the Treatment of Moderate to Severe Psoriasis

Cited by 11 publications

References 25 publications

Terapia biológica para la psoriasis moderada a severa

Terapia biológica para la psoriasis moderada a severa

Retorno social de la inversión de un abordaje ideal de la Psoriasis

Economic Burden and Cost Effectiveness Analysis of Psoriasis Treatment Modalities in Malaysian Public Hospitals: A Study Protocol

Contact Info

Product

Resources

About